Tegafur
Drug Details
- Description
- Tegafur is a prodrug of the anticancer agent 5-fluorouracil (5-FU) used in chemotherapy. It is often combined with other agents to enhance its efficacy and reduce side effects.
- Alternative Names
- Tegafur.
- Key Genes
- Key genes associated with Tegafur: DPYD, TYMS, MTHFR, and CYP2A6.
- Drug Use
- Tegafur is used primarily in the treatment of several types of cancers, including colorectal and gastric cancer. It is an antineoplastic agent that works by inhibiting DNA synthesis in cancer cells. Often, it is used in combination with other drugs like uracil and gimeracil.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report